Loading clinical trials...
Loading clinical trials...
An impaired ability to exert control has been implicated in bulimia nervosa (BN), but this impairment may not represent a stable trait or be the most effective focus for treatment. This project aims t...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
NCT07478510 · ARFID, Anorexia Nervosa, and more
NCT05614024 · Bulimia Nervosa
NCT04806620 · Post-Acute COVID-19 Syndrome, ME/CFS, and more
NCT05304104 · Binge-Eating Disorder, Bulimia Nervosa, and more
NCT06000774 · Anorexia Nervosa in Remission, Bulimia Nervosa, and more
Center of Excellence in Eating and Weight Disorders at the Icahn School of Medicine at Mount Sinai
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions